Furthermore, in a corresponding sublethal model, LZD therapy was associated with significantly improved bacterial clearance, attenuated MRSA – mediated ALI, and decreased concentrations of BALF protein and cytokines such as IL1β, IL6, IFN-γ and IL17. The gene discussed is IL1B; the disease is acute respiratory distress syndrome.